Posted on 26 December 202426 December 2024 FDA approves Mesoblast’s Ryoncil for SR-aGvHD treatment Mesoblast has gained US Food and Drug Administration (FDA) approval for its mesenchymal stromal cell (MSC) therapy, Ryoncil (reme...